Auricle develops a neurostimulation implant aimed at restoring hearing for patients who cannot benefit from traditional hearing aids.
Founded
2020
Revenue
$7.9M
Company Stage
Seed
YC Batch
W21
Product Features & Capabilities
neurostimulation implant for hearing restoration, designed for patients with severe hearing loss, minimally invasive approach, preserves residual hearing, targets high-frequency hearing loss, reversible implantation process
How much Auricle raised
Funding Round - $35 million
July 2023
Lead Investor: Microsoft M12 and other top US and European investors.